Treatment of 1,2-cyclohexanedione with 1,2-diamines, e.g. ethylenediamine and cis-(and trans-)1,2-diaminocyclohexane, caused [4ϩ2] cyclocondensation to give the corresponding dihydropyrazine derivatives (compounds 1-6). They exhibited stronger DNA strand-breakage activity than that of dihydropyrazines, which has already been reported in previous papers.
The biological relevance of dihydropyrazines (DHPs) continues to foster immense interest in their design and synthesis. DHPs are produced primarily from sugar in vitro. 1) Predictably, the formation of DHPs in vitro also occurs in vivo under non-enzymatic or enzymatic conditions. A number of pyrazine derivatives which are readily created from the DHP ring structure via oxidation 2) have been detected in human urine 3) and foods. [4] [5] [6] Thus, it is thought that DHPs are formed and found in vivo as precursors of pyrazine derivatives. For these reasons, we are interested in the effects of DHPs in vivo.
In our previous papers, 7-9) we discussed the synthesis and DNA strand-breakage activities of some DHPs, such as 2,3-dihydro-5,6-dimethylpyrazines (DHP-1, DHP-2 and DHP-3) (Fig. 1) . Recently, we also reported that DHPs cause apoptosis 10) and mutagenesis 11) in vivo. In this context, the synthesis of new DHPs provides an interesting challenge. Despite considerable interest in the DHP core among the medicinal and synthetic chemistry communities, we are not aware of any available routes that give the various substituted patterns. Indeed, very few examples of the synthesis of substituted DHPs have been reported. [12] [13] [14] In addition, few reports have been published on the biological and physiological roles of DHPs. In keeping with our interest in the synthetic chemistry and biological activity of DHPs, to investigate the hypothesis that intermediate (exo-type) DHPs might reveal higher DNA strand-breakage activity than other types, 15) we attempted to synthesize new DHPs and to elucidate their biological activity, including DNA strand-breakage activity, in vitro.
Preparation of Dihydropyrazines 1-6 The DHPs used in our investigation were synthesized via cyclocondensation of a-diketone and 1,2-diamines, according to our earlier work.
9) All synthesized products were too labile to exist at room temperature, but were fairly stable in the freezer. It is known that DHPs, such as DHP-1, DHP-2 and DHP-3 ( Fig. 1) , are unstable at room temperature. When an equimolar mixture of 1,2-cyclohexanedione and ethylenediamine (ED) in chloroform was stirred at room temperature for 24 h, the expected hexahydroquinoxaline derivative 1 16) was ob- On the basis of these observations, it seems likely that the ratio of the two isomers depends on the solvent. The above spectral studies confirmed the formation of the desired DHP derivative 1, which was characterized as 1,2,3,5,6,7-hexahydroquinoxaline (1A) or 2,3,5,6,7,8-hexahydroquinoxaline (1B). The treatment of 1,2-cyclohexanedione (1.0 equiv.) with ED (2.0 equiv.) in chloroform at room temperature for 24 h afforded 4a,8a-butanodecahydropyrano [2,3-b] pyrazine (2) 17) as a pale yellow solid in 54% yield (Chart 1 in CD 3 CN at room temperature shows only the sum of 1B and ED, whereas that of 2 in CD 3 CN at Ϫ40°C shows peaks for the methylene protons (H-2, -3, -6 and -7) of 2 in the range 2.96-3.18 ppm. The 13 C-NMR spectrum of 2 in CD 3 CN at Ϫ40°C displays signals at d 42.5 due to the C-2, -3, -6 and -7 carbons and at d 66.9 due to the C-4a and -8a carbons (see references and notes 17). This implies that compound 2 can easily dissociate in the solvent, such as CD 3 CN, CDCl 3 and D 2 O, as is the case for DHPs reported in our earlier work. 18, 19) In this case, we did not observe 1A at all, which suggests that when compound 2 dissociates in this solvent, 1B is formed as a single isomer. Although the calculation of heat of formation by 6-31G* indicated that 1B is more stable than 1A, with a difference of 3.73 kcal/mol, it is not clear why 1A is not formed. The experimental data suggests that the interconversion of 1B to 1A cannot proceed in the presence of ED. In a similar way, by reaction of 1,2-cyclohexanedione with cis-(and trans-)1,2-diaminocyclohexane, DHPs 3-6 were obtained in 38, 34, 41 and 20% yield, respectively (Fig. 2) . Similarly to 1 and 2, the isomerization of decahydrophenazines 3 and 5 and the dissociation of 5a,11a-butanooctadecahydroquinoxalino[2,3-b]quinoxalines 4 and 6 were observed in 1 H-NMR solvents. The structural assignments of 3-6 were made on the basis of spectral data.
Evaluation of DNA Strand-Breakage Activity by Dihydropyrazines 1-6 DNA strand-breakage activity data are summarized in Table 1 , compared with the activity of DHP-1 as detailed in a previous paper. DNA strand-breakage activity is accelerated to a remarkable degree by the addition of cupric ions (Cu 2ϩ ), which may stimulate the production of active radicals, 20) resulting in DNA strand-breakage. The generation of radicals as well as DHP-1 was detected (data not shown); the details will be published in a later paper. The values obtained for activity were based on the remaining amounts of covalently closed circular duplex DNA (ccc-DNA) of plasmid pBR322. 21, 22) In the absence of Cu 2ϩ , 4-6 showed higher activity than DHP-1, and these activities were obviously accelerated by the addition of 1 mM Cu 2ϩ (entries 5-7). Furthermore, in the presence of Cu 2ϩ , it was found that all compounds 1-6 have higher activity than that of DHP-1.
In conclusion, we have prepared six new DHP compounds 1-6, which show high DNA strand-breakage activity in vitro with or without Cu 2ϩ . Our results suggest that these new DHPs may play a role in vivo. Further studies on the biological activity of DHPs are under way. , the quantity of DHPs and the incubation time were minimized until differences in activity could be observed. 
